Related Experiment Video
Updated: Jan 25, 2026

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Role of beta-2-microglobulin as a biomarker in very preterm and extremely preterm infants with CNS inflammation
Albert Batista Muñoz1, Stephanie Hadley2, Marti Iriondo Sanz1
1BCNatal | Barcelona Center for Maternal Fetal and Neonatal Medicine, Hospital Sant Joan de Déu and Hospital Clínic, University of Barcelona, Esplugues de Llobregat, Spain.
Background:
Premature infants are at risk for severe sepsis and meningitis, both infections associated with high mortality and morbidity. Cerebro-spinal fluid (CSF) culture is the gold standard method for meningitis diagnosis, but interpretation of biochemical parameters of CSF is essential at the moment of the analysis in order to start the appropriate treatment. The main objective of this study was to determine whether levels of CSF beta-2-microglobulin (B2M) were elevated in preterm infants with CNS infections or other inflammatory processes, and to establish if there were differences in B2M concentrations amongst various inflammatory settings (sepsis, meningitis, and progressive post-hemorrhagic ventricular dilatation (PHVD)).
Methods:
This is a retrospective study of all very preterm and extremely preterm infants (< 32 weeks of gestation) admitted to our NICU between 2012 and 2017. All those who underwent a lumbar puncture during their stay as part of a sepsis work-up or PHVD were considered for inclusion. CSF biochemical parameters and B2M were tested in all of the patients.
Results:
Fifty-nine patients were included in the study. In patients with CNS infections, the median value of B2M was 8.69 mg/L (3.92-18.5). B2M levels above 3.92 mg/L showed greater sensitivity and specificity than leukocyte levels in discriminating between patients with CNS infections or other inflammatory processes and those without CNS inflammation.
Conclusions:
In this population, CSF B2M proved to be an effective biomarker to discriminate between patients with CNS infections and other inflammatory processes and those without CNS inflammation.
Insights
Cerebrospinal fluid beta-2-microglobulin (B2M) effectively identifies central nervous system infections in preterm infants. Elevated B2M levels are more sensitive and specific than leukocytes for diagnosing these serious conditions.
Area of Science:
- Neonatal Medicine
- Infectious Diseases
- Biomarker Research
Background:
- Premature infants face high risks of sepsis and meningitis, leading to significant mortality and morbidity.
- Accurate diagnosis of central nervous system (CNS) infections in neonates is critical for timely treatment.
- Cerebrospinal fluid (CSF) analysis is key, but biochemical markers need further validation.
Purpose of the Study:
- To investigate elevated CSF beta-2-microglobulin (B2M) levels in preterm infants with CNS infections or inflammatory conditions.
- To differentiate B2M concentrations across various inflammatory settings like sepsis, meningitis, and post-hemorrhagic ventricular dilatation (PHVD).
Main Methods:
- Retrospective study of very and extremely preterm infants (< 32 weeks gestation) admitted between 2012-2017.
- Inclusion criteria: lumbar puncture for sepsis work-up or PHVD.
- Analysis of CSF biochemical parameters and B2M levels in all included patients.
Main Results:
- Fifty-nine preterm infants were included in the analysis.
- Median B2M levels were 8.69 mg/L in infants with CNS infections.
- B2M levels > 3.92 mg/L demonstrated superior sensitivity and specificity compared to leukocytes in distinguishing CNS inflammation.
Conclusions:
- CSF B2M is a valuable biomarker for differentiating CNS infections from other inflammatory processes in preterm infants.
- B2M aids in distinguishing inflammatory conditions from non-inflammatory states in this vulnerable population.
Related Concept Videos
Inflammation
Absolute and Local Extreme Values
CNS Depressants: Alcohol and Nicotine
CNS Depressants: Barbiturates and Benzodiazepines
CNS Stimulants: Psychedelic Agents
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

